Skinvisible Inc (SKVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats.
The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights Skinvisible Inc (Skinvisible) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. carries out formulation and licensing of products in the fields of dermatology, surgical preparation, consumer healthcare and others. The company develops topical polymer delivery vehicles and other compositions to hold active ingredients of skincare products on skin for extended period of time. It develops products for established brand manufacturers and marketers of prescription and over-the-counter (OTC) dermatological, medical, cosmetic and skincare products. The company licenses its patented polymer delivery vehicle, Invisicare to leading national and international dermatological, cosmetic, medical, skincare and consumer goods manufacturers and distributors. Skinvisible is headquartered at Las Vegas in Nevada, the US.
Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
183 pages •
By Persistence Market Research
• Nov 2018
Facial Injectable Market: Global Industry Analysis 2012-2016 & Opportunity Assessment 2017-2028 A recent market study “Facial Injectable Market: Global Industry Analysis 2013-2017 & Forecast 2018-2028” consists a comprehensive assessment of the most important market dynamics.On conducting a thorough research on the historic...
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Animal Health Market. The study on global animal health market has been analyzed By Type (Farm animal,...
The global oral care market is expected to reach US$ 60,804.8 Mn by 2025 from US$ 42,689.6 Mn in 2017. The oral care market is estimated to grow with a CAGR of 4.6% during the forecast period from 2018 to 2025. The growth of the oral care market is primarily attributed to the rising prevalence of oral diseases, increasing technological advancements...
Japanese Encephalitis - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Japanese Encephalitis - Pipeline Review, H2 2018, provides an overview of the Japanese Encephalitis (Infectious Disease) pipeline landscape. Japanese...
Urinary Retention Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Urinary Retention Global Clinical Trials Review, H2, 2018" provides an overview of Urinary Retention clinical trials scenario.This report provides top line data relating to the clinical trials on...
Hepatitis C - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H2 2018, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. Hepatitis C is a contagious viral infection...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.